Abstract The role of endothelin (ENT) in the control of systemic blood pressure (BP) was examined in conscious rats. Intracerebroventricular (i.c.v.) administration of ENT (0.002 or 0.2 jig, i.e., 0.78 or 78 pmol/2 µl 0.9% saline) to conscious rats had complicated effects on BP. A significant fall in BP occurred in the initial 2-4 min after administration; and then after recovery toward the control level, BP decreased again within 17 min, following which a constant rise in BP occurred. In addition to the changes in BP, 3 of 9 rats which received 0.2 µg lapsed into severe barrel rotation-like behavior only to die 6-8 min after i.c.v. injection. It was therefore assumed that ENT had central effects on BP regulation and motor activity.
Endothelin (ENT), which has been isolated from the cultured media of porcine aortic endothelial cells, is a novel vasoactive peptidergic factor which causes or enhances endothelium-dependent vasoconstriction, and induces hypertension when given peripherally (YANAGISAWA et al., 1988b) . There are many reports with respect to the physiological effects of neuroactive peptides when administered into the cerebral ventricle of rats. Except angiotensin II, which produces a pressor response when injected centrally as well as peripherally, several other peptides such as bradykinin (BROOKS et al., 1986) , neutrotensin (SUMNERS et al., 1982) , and vasoactive intestinal polypeptide (CASTO and PHILLIPS, 1983) cause hypertension after central administration despite the hypotensive effects when introduced peripherally.
On the other hand, it is suggested that ENT is an endogenous agonist of Ca channels (YANAGISAWA et al., 1988a, b) . Ca channels play a significant role in neural conduction as well as vascular smooth muscle contraction. In the present study, the experiments were designed to examine systemic blood pressure (BP) when ENT is injected into the third ventricle in conscious rats for the purpose of elucidating the central action of ENT, although there are no reports concerned with the presence of ENT in the central nervous system (CNS).
MATERIALS AND METHODS
Animals and surgery. Male rats of Wistar strain weighing 250-350 g were used in the present study. They were maintained in a light-(lights on 05.00-19.00 h) and temperature-(24°C) controlled room and allowed free access to food and water.
For drug injections, the animals were stereotaxically implanted with guide cannulae, made of 0.65 mm outer diameter stainless-steel tube, into the third ventricle at the level of preoptic-anterior hypothalamic region according to the atlas of ALBE-FESSARD et al. (1966) . The operations were performed under sodium pentobarbital anesthesia of 31.5 mg/kg BW i.p. The cannulae were fixed to the skull with dental cement and stainless-steel screws. An inner cannula, with a 0.35 mm outer diameter, was prepared for each of the guide cannula at the time of surgery so as to protrude approximately 0.50 mm beyond the tip of the guide cannula. The guide cannula was plugged with a dummy inner cannula until the day of the experiment.
Blood pressure measurement. To adapt the animals to the measuring conditions, BP was measured weekly for a period of 4 weeks prior to the injection experiment. More than 3 measured values were taken and averaged for each measurement. The pulse rate of the tail artery (heart rate, HR) readings which were recorded simultaneously were also averaged. Injection experiments were performed 3 to 4 weeks after the i.c.v. implantation of guide cannulae.
Systolic BP and HR were measured in conscious rats by the indirect tail-cuff technique using a rat-tail manometer-tachometer system (KN-210, Natsume Seisakusho Co. Ltd., Tokyo, Japan). Prior to the measuremet, the animals were preheated for 10 min with a warm plate in order to dilatate tail artery enough to measure BP. The BP was measured 5 min before (control) and during the administration, followed by measurements at 30-s intervals afterward.
Drug administration. Synthetic ENT, porcine/human ENT or ENT1 (The Peptide Institute, Minoo, Japan) was dissolved in 0.9% saline to the final concentration. Then 0.002 or 0.2µg, i.e., 0.78 or 78 pmol ENT, respectively, in a volume of 2 µl was injected into the third ventricle through the inner cannula, using a 10 µl microsyringe attached to the inner cannula via Silastic tubing. The injection speed was as low as 1 µl per min. Control rats received the same volume of normal saline.
Statistical analysis. rats and in rats with the ENT injection at corresponding times.
RESULTS
Mean (+S.E.M.) BP values for all the animals which received i.c.v. injection of ENT (Fig. 1 ) reproduced these characteristics, suggesting that the rise and drop in the BP after ENT injection did not occur randomly, but occurred at rather fixed time among animals.
Injections of 2.0 tl saline alone produced no significant changes in the mean BP during the period of more than 10 min as compared to the values before the injection. The mean HR also did not change significantly. The i.c.v. injection of 0.002 , ig ENT produced about a 15 mmHg depression in mean BP 4 min after starting the injection, which recovered toward the pre-injection control levels immediately, and the BP alteration within 20 mmHg continued. A significant rise in the mean BP value of about 30-40 mmHg began 12 min after starting the injection, and returned toward the control level 17 min after injection once and rose again to the maximum rapidly. When 0.2,ig was injected, the mean BP rose about 20 mmHg as soon as i.c.v. injection started, following which a significant depression of about 20 mmHg beneath the control values occurred and continued for 1 min. After that, the mean BP value began to rise again to 30-40 mmHg beyond the control level, accompanied with BP fluctuation in the range of 15-25 mmHg. The mean BP value once returned toward the control level 17.5 min after injection as well as in the case of 0.002 µg injection and rose to the maximum immediately.
The i.c.v. injection of 0.002 µg ENT induced gradual increase in the mean HR value to 30-40 bpm over the control values till 17 min after injection, following which it decreased 50 bpm accompanying the BP rise. When 0.2,tg was injected, although the mean HR did not change significantly till 10 min after the injection, it decreased 70-80 bpm as the BP increased after fluctuating greatly in the 40-50 bpm range (Fig. 2) .
In addition, 3 out of 9 rats which received 0.2, tg ENT showed barrel rolling behavior, accompanied by a distorted head and body position, lack of spontaneous motor activity other than rotation, and tachycardia and apnea 6-8 min after injection. All 3 rats died of respiratory arrest another 1-2 min later. On the other hand, no such abnormal rotational behavior was seen in the rats which received 0.002 µg ENT.
DISCUSSION
The present study demonstrates that the i.c.v. administration of ENT causes certain but complicated effects on systemic BP in conscious rats. When ENT was administered, BP rose simultaneously with the beginning of the injection and then fell significantly, following which a rise in BP with a large fluctuation was shown, and a transient but significant fall also occurred around 17 min after injection. However, it may be possible to say that the major effect of centrally administered ENT is an induction of hypertension. The fact that the BP changes, including rise and fall, in 0.002 ,ug ENT administration approximated those in 0.2 µg, but the change was greater in 0.2 µg ENT administration, might indicate that i.c.v, effects Japanese Journal of Physiology of ENT on BP were dose-dependent phenomena. It appears that the changes in the mean HR value tend to follow those in the mean BP value faithfully; decreases or increases in the HR accompany a rise or fall in the BP, respectively. Although the accuracy of indirect blood pressure determination in unanesthetized animals depends on many factors, such as the location of the cuff on the tail, the cuff width, the body temperatures of the rat, and the extent of restraint when measured, an adequate selection of measuring conditions, described above, has been shown to result in a satisfactory agreement between the indirect measurement and direct intraarterial measurement (MAISTRELLO and MATSCHER, Vol. 39, No. 6, 1989 For further 1969; BUNAG, 1973; NORMAN et al., 1981) . There is no evidence for the presence of ENT in the CNS. However, it is probable that ENT directly exerts an effect upon the neurons in the CNS, since it is suggested that ENT is an endogenous agonist of Ca channels (YANAGISAWA et al., 1988a, b) , which play a significant role in neural conduction as well as in vascular smooth muscle contraction. On the other hand, since peptides can be rapidly distributed into the brain interstitial space of the circumventricular organs, i.e., about six small regions around the ventricles which lack a blood-brain barrier (WEINDL, 1973) , and the cerebrospinal fluid (CSF) is capable of transmitting information from one area of the brain to another by virture of special nerve cells with processes straight into the CSF (VIGH and VIGH-TEICHMANN, 1973) , it is probable that i.c.v. injected ENT is capable of influencing the neurons in the CNS.
The observation that decreases in the HR tended to occur concomitantly with increases in the BP following central injection of ENT indicates that the vagal component of the baroreceptor reflex is not so attenuated. There is a general agreement that the vagi may profoundly depress the pacemaker cells, the cardiac conduction system, and the myocardial contractility, and induces a reduction in the HR and the systolic pressure in response to the acute potent hypertension (OBERG, 1976; DOWNING, 1979; LEVY and MARTIN, 1979) . The cardiovascular response to centrally injected ENT could be thus related to the selective sympathetic outflow toward the blood vessels. Further, if such a sympathetic outflow is increased by the ENT as above, the transient fall in the pressure can be interepreted as an accentuated vagal-sympathetic antagonism, which is a phenomenon that the negative chronotropic and inotropic effects of vagal activity become more pronounced with greater prevailing levels of tonic sympathetic activity (LEVY and MARTIN, 1979) .
At the same time, a large fluctuation in the BP after injection of ENT is similar to that resulting from the baroreceptor-denervation; in general, BP variations during the day are more pronounced in the baroreceptor-denervated animals than in normal animals (OBERG, 1976; NORMAN et al., 1981) .
It is therefore assumed that the centrally injected ENT produces an elimination of the baroreceptor reflex, to such an extent that increases the arterial pressure lability, but buffers the acute potent BP elevation, and then the selective sympathetic stimulation for the blood vessels precedes the elimination of the baroreceptor reflex.
An alternative possibility could be that regional hypoxia arising from the vasoconstriction within the brain, particularly in the area related to the cardiovascular regulation, is responsible for the central ENT effects on BP, if the i.c.v. injected ENT is capable of constricting the blood vessels within the brain as in the case of the coronary artery (HICKEY et al.,1985; YANAGISAWA et a1.,1988a, b) .
Furthermore, if so, it is possible that the reduction of the total blood supply to the brain due to the vasoconstriction elicits a rise of systemic BP, a response referred to as the Cushing response (HOFF and REIS, 1970; DOBA and REIs, 1972) . Ischemia or hypoxia in the brain is likely to be one of the adequate stimuli for the Cushing response (DICKINSON and MCCUBBIN, 1962 is hardly significant in the present study in spite of the fact that the genuine Cushing response accompanies a bradycardia. ENT provoked unusual rotational behavior along the longitudinal body axis, i.e., barrel rotation. These barrel rotations have also been reported after i.c.v. injection of somatostatin (CoHN and COHN, 1975) , substance P (CARLSSON et al., 1977) , and sulfated C-terminal 7-peptide of cholecystokinin (MANN et a!., 1980) in a dose of 25-50,ug per rat, and of vasopressin and vasopressin-analogues (KRUSE et a!.,1977) in a dose of 0.008-5 µg. ENT was thought to be more potent in eliciting barrel rotation than such peptides, since 3 out of 9 rats developed this unusual rotation at a dose of only 0.2 µg. Although the mechanism of action of ENT-induced rotations is unknown, from the description of barrel rotations following these peptides mentioned above (CoHN and CoHN, 1975; CARLSSON et al., 1977; KRUSE et al., 1977; MANN et a!., 1980) and our own observation, it appears that central injections of peptides induce a common syndrome. It is therefore possible that we are dealing with an unspecific, and probably toxic effect, since all rats that showed barrel rotation died of respiratory arrest.
The present study of Inoue
